An ultra-portable, PCR-quality diagnostics platform for COVID and beyond.
The UOL COVID-19 Test is an FDA-authorized, PCR-quality COVID test system that returns results in as fast as 12 minutes with a 96.1% Accuracy compared to high-sensitivity PCR - all for a lower cost than other CLIA-waived COVID NAATs.
The UOL COVID-19 Test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting and is available for purchase by qualified customers with a CLIA ID. Uh-Oh Labs does not provide COVID testing services.
A new test for the new normal.
The UOL COVID-19 Test uses a new, patented chemistry which is ideally suited for detection of infectious disease: Loop-de-Loop™ RT-LAMP.
Loop-de-Loop™ RT-LAMP allows for the power of PCR without complex equipment. The result? Lower costs while maintaining accuracy.
Meeting your testing needs today (and tomorrow).
Test Features
Fast Results: Positive results in as fast as 12 minutes, negative results in 40 minutes.
Highly Accurate: 96.1% Accuracy with no false positives when compared to a highly-sensitive PCR test.
Powerful Detection: Analytical sensitivity over 20,000x higher than some commercially-available rapid antigen tests.
Easy Workflow: Anterior nasal swab sample collection, set up and run a test in under 5 minutes.
Clear Results: Mobile app automatically interprets data with clear-text results.
Tech Enabled: Patient registration, SMS result delivery, and automated reporting also available*.
Beyond COVID: Additional tests utilizing the UOL COVID-19 Instrument in development
*additional software integration required, contact sales for more info.
Supported by leading institutions and investors.
Uh-Oh Labs is developing diagnostic tests through our Loop-de-Loop™ platform which enables simplicity, speed, and lower costs while providing accurate, lab-grade results.
We are led by a team of experts in molecular diagnostics and bioengineering and are supported by the National Institute of Health’s Rapid Acceleration of Diagnostics (RADx) initiative and private investors, including Y Combinator.
With Support From
